Analyses highlight long-term efficacy and safety results, including real-world data, from studies of SKYRIZI® (risankizumab) in moderate to severe psoriasis and active psoriatic arthritis Presentations include data from the largest-of-its-kind study that… Read More
By Lillian Roy, CTVNewsMontreal.ca Digital Reporter. Contact A lone bandage floating in a kiddie pool. Medical tape peeling up at the edges. Adhesives gone rogue in the gastrointestinal space. Could… Read More
CAMBRIDGE, MA. — Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, today announced that it has entered into an agreement with Acuitas Therapeutics, a… Read More
Gift supports effort to build a pipeline of Black leaders to bring diversity to decision-making as industry confronts new challenges CHICAGO — A $150,000 gift from the Deloitte* Health Equity… Read More
Indonesia National Agency for Drug and Food Control, BPOM, Approved QDENGA (TAK-003) for Use in Individuals Six Years to 45 Years of Age1 QDENGA is the Only Dengue Vaccine Approved in Indonesia… Read More
